MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • 2018 International Congress

    The Use of Technology-Enabled Care (TEC) in Patients with Parkinson’s Disease: An Italian Survey

    C. Di Nuzzo, R. Ferrucci, L. Bertolasi, L. Lo Piano, N. Modugno, M. Onofrj, C. Pacchetti, F. Stocchi, F. Tamma, S. Marceglia, F. Mancini, A. Priori (Milan, Italy)

    Objective: The present survey aims to explore the use and need of connected health or technology-enabled care (TEC) in patients with Parkinson's disease (PD) in…
  • 2018 International Congress

    Voluntary suppression of Parkinson’s tremor

    R. Blakemore, M. MacAskill, D. Myall, T. Anderson (Christchurch, New Zealand)

    Objective: To provide the first detailed systematic investigation of the phenomenon of voluntary tremor suppression in Parkinson’s disease (PD). Background: We have observed in the…
  • 2018 International Congress

    Neuroprotective potential of curcumin in combination with piperine against 6-hydroxy dopamine induced motor deficit and neurochemical alterations in rats

    S. Singh (Moga, India)

    Objective: (1) Curcumin is well tolerated curcuminoid used as supplement for various disorders but problem is its low oral bioavailability. (2) Piperine is combined to…
  • 2018 International Congress

    Balance and gait analysis of GBA mutation carriers with Parkinson’s disease (PD)

    A. Gera, J. Okeefe, N. Purcell, C. Huml, S. Ruehl, B. Ouyang, G. Pal (Chicago, IL, USA)

    Objective: To use quantitative inertial sensor-based postural sway and gait analysis to determine potential differences in the pattern of balance and gait impairment in the…
  • 2018 International Congress

    Lack of TMEM230 mutations in patients with familial and sporadic Parkinson’s disease in a Taiwanese population

    T. Fan, C. Lin, H. Lin, M. Chen, R. Wu (Taoyuan, Taiwan)

    Objective: To confirm the role of mutations in transmembrane protein 230 (TMEM230) in a large number of PD patients and controls in a Taiwanese population.…
  • 2018 International Congress

    Kufor-Rakeb syndrome and a rare ATP13A2 missense mutation in a Portuguese patient

    H. Salhi, S. Montaut, D. Devos, J. Chelly, F. Galacteros, P. Brugières, P. Remy, G. Fenelon (Créteil, France)

    Objective: To describe a genetically proven case of Kufor-Rakeb syndrome (KRS) in a young portuguese patient with juvenile parkinsonism. Background: Mutations in the ATP13A2 gene…
  • 2018 International Congress

    Transcranial imaging of substantia nigra hyperechogenicity in a Chinese cohort of Parkinson’s disease

    G. Hongling, Y. Qingmei (Wuhan, China)

    Objective: In this research we set out to study the diagnostic value of TCS in Parkinson's disease. Background: An increased echogenicity of the substantia nigra…
  • 2018 International Congress

    Striatal dopamine uptake and olfactory dysfunction in patients with early Parkinson’s disease

    YS. Oh, DW. Ryu, JS. Kim, CH. Lyoo (Seoul, Republic of Korea)

    Objective: To identify dopamine transporter status of corpus striatum and thalamus using magnetic resonance imaging-guided spatial normalization method in patients with PD according to olfactory…
  • 2018 International Congress

    Alterations of cortical metabotropic glutamate receptor-mediated signaling in patients with Parkinson’s disease

    JY. Lee, YK. Kim, SA. Shin, SH. Seo, JS. Lee, YS. Lee, JM. Jeong, B. Jeon (Seoul, Republic of Korea)

    Objective: To evaluate expression of brain metabotropic glutamatergic receptor 5 and the relationship with clinical measures in Parkinson’s disease patients. Background: Metabotropic glutamate receptor 5…
  • 2018 International Congress

    The study of 18F-FDG PET / CT imaging in the value on Parkinson’s disease

    Z. Mao, Z. Xue (Hubei, China)

    Objective: In this study,we were to investigate imaging characteristics of 18F-FDG PET/CT in patients with Parkinson's disease (PD), and explore its value on PD. Background:…
  • « Previous Page
  • 1
  • …
  • 253
  • 254
  • 255
  • 256
  • 257
  • …
  • 405
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • #23139 (not found)
  • Effect of marijuana on Essential Tremor: A case report
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley